Hypericin and Naringenin Exert no Significant Synergistic Apoptotic Effect on Y79 Retinoblastoma Cell Line

Synergistic Effect of Hypericin and Naringenin on Y79

Authors

  • Hamid Zaferani Arani Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
  • Zahra Abbasy Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran
  • Seyed Mahmoud Reza Hashemi Rafsanjani Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Nastaran Fooladivanda Department of Pathology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
  • Mahdi Kheradmand Department of Psychology, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran
  • Fateme Shariati Far Department of Nursing, Student Research Center, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Internal-surgery Trend, Iran
  • Dena Saghafi Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Amirhossein Shekarriz Faculty of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran
  • Mojdeh Barati Department of Marine science, Science & Research Branch, Islamic Azad University, Tehran, Iran
  • Farzaneh Nasirimotlagh Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Fatemeh Ziyadloo Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
  • Arefe Nekuifard Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Narges Farajee Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Mohammadreza Letafat Department of Marine science, Science & Research Branch, Islamic Azad University, Tehran, Iran
  • Marzieh Mehri Tokmeh Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Nastaran Teymoorianfard Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Bita Massah Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Mohammad Amin Javidi Department of Integrative Oncology, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

DOI:

https://doi.org/10.31661/gmj.v13i.3347

Keywords:

Retinoblastoma; Herbal Medicine; Apoptosis

Abstract

Background: According to the anti-cancer impact of hypericin and naringenin, we put the main aim of this study to unravel the apoptotic/anti-cancer effect of these compounds on Y79 retinoblastoma cell line. Materials and Methods: To calculate the 50%inhibitory concentration (IC50) of hypericin for 24 and 48 hours, XTT assay performed. Cytotoxic effect of naringenin investigated by XTT and trypan blue exclusion assay further confirmed the inhibitory impact of these agents on Y79 cells viability. Flow cytometry Annexin V/PI determined the cell death. The mRNAs expression level of Bax and Bcl-2 investigated by real-time PCR in different groups including the control, cells treated with naringenin, hypericin, or concurrent with both compounds. Results: The 24 and 48 hours IC50 of hypericin, calculated to be 2.5 and 1.25 (μg/ml), respectively. 50 (μg/ml) naringenin induced about 20% and 30% apoptosis in Y79 cells after 24 and 48 hours. Trypan blue staining and flow cytometry confirmed this data. Moreover, flowcytometry results, revealed that the kind cell death occurred in these cells post treatment was mostly apoptosis. Simultaneous treatment with both agents didn’t show synergistic effect. Bax/Bcl-2 ratio increased in cells treated with hypericin but in cells treated with narigenin didn’t show significant increase in the Bax mRNA level. Conclusion: Hypericin had more cytotoxic effect in Y79 cells compared with naringenin. Furthermore, hypericin and naringenin didn’t have apoptotic synergistic effect in these cells. According to the real-time PCR results, hypericin induces apoptosis in Y79 cells by disrupt the ratio of Bax/Bcl-2.

References

Kotecha R, Takami A, Espinoza JL. Espinoza, Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget. 2016;7(32):52517-52529.

https://doi.org/10.18632/oncotarget.9593

PMid:27232756 PMCid:PMC5239570

Stagos D, Amoutzias GD, Matakos A, Spyrou A, Tsatsakis AM, Kouretas D. Chemoprevention of liver cancer by plant polyphenols. Food Chem Toxicol. 2012;50(6):2155-70.

https://doi.org/10.1016/j.fct.2012.04.002

PMid:22521445

Javidi MA, Kaeidi A, Farsani SS, Babashah S, Sadeghizadeh M. Investigating curcumin potential for diabetes cell therapy, in vitro and in vivo study. Life Sci. 2019;239:116908.

https://doi.org/10.1016/j.lfs.2019.116908

PMid:31610197

Javidi MA, Zolghadr F, Babashah S, Sadeghizadeh M. Introducing Dendrosomal Nanocurcumin as a Compound Capable of in vitro Eliminating Undifferentiated Stem Cells in Cell Therapy Practices. Exp Clin Endocrinol Diabetes. 2015;123(10):632-6.

https://doi.org/10.1055/s-0035-1555775

PMid:26179929

Mir IA, Tiku AB. Chemopreventive and therapeutic potential of "naringenin," a flavanone present in citrus fruits. Nutr Cancer. 2015;67(1):27-42.

https://doi.org/10.1080/01635581.2015.976320

PMid:25514618

Nelson HD, Fu R, Humphrey L, Smith ME, Griffin JC, Nygren P. Comparative effectiveness. of medications to reduce risk of primary: breast cancer in women; 2009.

https://doi.org/10.7326/0000605-200911170-00147

PMid:19920271

Felgines C, Texier O, Morand C, et al. Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol. 2000; 279(6): G1148-54.

https://doi.org/10.1152/ajpgi.2000.279.6.G1148

PMid:11093936

Bodet C, La VD, Epifano F, Grenier D. Naringenin has anti‐inflammatory properties in macrophage and ex vivo human whole‐blood models. J Periodontal Res. 2008;43(4):400-407.

https://doi.org/10.1111/j.1600-0765.2007.01055.x

PMid:18503517

Lee CH, Jeong TS, Choi YK, et al. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun. 2001;284(3):681-8.

https://doi.org/10.1006/bbrc.2001.5001

PMid:11396955

Totta P, Acconcia F, Leone S, Cardillo I, Marino M. Mechanisms of Naringenin‐induced Apoptotic Cascade in Cancer Cells: Involvement of Estrogen Receptor a and ß Signalling. IUBMB life. 2004;56(8):491-499.

https://doi.org/10.1080/15216540400010792

PMid:15545229

Park JH, Jin CY, Lee BK, Kim GY, Choi YH, Jeong YK. Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol. 2008;46(12):3684-3690.

https://doi.org/10.1016/j.fct.2008.09.056

PMid:18930780

Arul D, Subramanian P. Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res. 2013;19(4):763-770.

https://doi.org/10.1007/s12253-013-9641-1

PMid:23661153

Hatkevich T, Ramos J, Santos-Sanchez I, Patel YM. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells. Exp Cell Res. 2014;327(2):331-339.

https://doi.org/10.1016/j.yexcr.2014.05.017

PMid:24881818

Jin CY, Park C, Lee JH, et al. Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells. Toxicol in Vitro. 2009;23(2):259-265.

https://doi.org/10.1016/j.tiv.2008.12.005

PMid:19124070

Frydoonfar HR, McGrath DR, Spigelman AD. Spigelman, The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin. Colorectal Dis. 2003;5(2):149-152.

https://doi.org/10.1046/j.1463-1318.2003.00444.x

PMid:12780904

Lentini A, Forni C, Provenzano B, Beninati S. Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential. Amino acids. 2007;32(1):95-100.

https://doi.org/10.1007/s00726-006-0304-3

PMid:16699821

Subramanian P, Arul D. Attenuation of NDEA‐induced hepatocarcinogenesis by naringenin in rats. Cell Biochem Funct. 2013;31(6):511-517.

https://doi.org/10.1002/cbf.2929

PMid:23172681

Gamasaee NA, Radmansouri M, Ghiasvand S, et al. Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231. Arch Iran Med. 2018;21(9):387-392.

Hosseini MM, Karimi A, Behroozaghdam M, et al. Cytotoxic and Apoptogenic Effects of Cyanidin-3-Glucoside on the Glioblastoma Cell Line. World Neurosurg. 2017;108:94-100.

https://doi.org/10.1016/j.wneu.2017.08.133

PMid:28867321

Mirmalek SA, Jangholi E, Jafari M, Yadollah-Damavandi S, Javidi MA, Parsa Y, et al. Comparison of in Vitro Cytotoxicity and Apoptogenic Activity of Magnesium Chloride and Cisplatin as Conventional Chemotherapeutic Agents in the MCF-7 Cell Line. Asian Pac J Cancer Prev. 2016;17(S3):131-4.

https://doi.org/10.7314/APJCP.2016.17.S3.131

PMid:27165250

Schempp CM, Kirkin V, Simon-Haarhaus B, et al. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St John's wort that acts by induction of apoptosis. Oncogene. 2002;21(8):1242-1250.

https://doi.org/10.1038/sj.onc.1205190

PMid:11850844

Skalkos D, Stavropoulos NE, Tsimaris I, et al. The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells. Planta Med. 2005;71(11):1030-5.

https://doi.org/10.1055/s-2005-873127

PMid:16320204

Quiney C, Billard C, Faussat AM, et al. Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia. Leukemia. 2006;20(3):491-7.

https://doi.org/10.1038/sj.leu.2404098

PMid:16424868

Zhao H, Dugas N, Mathiot C, et al. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood. 1998;92(3):1031-43.

https://doi.org/10.1182/blood.V92.3.1031

PMid:9680373

Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ice)-like and cysteine protease protein (cpp)-32-like proteases. J Exp Med. 1997; 185(4):601-608.

https://doi.org/10.1084/jem.185.4.601

PMid:9034139 PMCid:PMC2196141

Odashiro AN, Pereira PR, Souza Filho JP, Cruess SR, Júnior B, Nascente MN. Retinoblastoma in an adult: case report and literature review. Can J Ophthalmol. 2005;40(2):188-91.

https://doi.org/10.1016/S0008-4182(05)80032-8

PMid:16049534

Mietz H, Hutton WL, Font RL. Font, Unilateral retinoblastoma in an adult: report of a case and review of the literature. Ophthalmology. 1997;104(1):43-7.

https://doi.org/10.1016/S0161-6420(97)30363-7

PMid:9022103

Darwich R, Ghazawi FM, Rahme E, et al. Retinoblastoma Incidence Trends in Canada: A National Comprehensive Population-Based Study. J Pediatr Ophthalmol Strabismus. 2019;56(2):124-130.

https://doi.org/10.3928/01913913-20190128-02

PMid:30889267

Stacey AW, Clarke B, Moraitis C, et al. The Incidence of Binocular Visual Impairment and Blindness in Children with Bilateral Retinoblastoma. Ocul Oncol Pathol. 2019;5(1):1-7.

https://doi.org/10.1159/000489313

PMid:30675470 PMCid:PMC6341332

Nguyen SM, Sison J, Jones M, et al. Lens Dose-Response Prediction Modeling and Cataract Incidence in Patients With Retinoblastoma After Lens-Sparing or Whole-Eye Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019;103(5):1143-1150.

https://doi.org/10.1016/j.ijrobp.2018.12.004

PMid:30537543 PMCid:PMC6667833

Rashmi R, Magesh SB, Ramkumar KM, Suryanarayanan S, SubbaRao MV. Antioxidant Potential of Naringenin Helps to Protect Liver Tissue from Streptozotocin-Induced Damage. Rep Biochem Mol Biol. 2018;7(1):76-84.

Downloads

Published

2024-04-28

How to Cite

Zaferani Arani, H., Abbasy, Z., Hashemi Rafsanjani, S. M. R., Fooladivanda, N., Kheradmand, M., Shariati Far, F., … Javidi, M. A. (2024). Hypericin and Naringenin Exert no Significant Synergistic Apoptotic Effect on Y79 Retinoblastoma Cell Line: Synergistic Effect of Hypericin and Naringenin on Y79. Galen Medical Journal, 13, e3347. https://doi.org/10.31661/gmj.v13i.3347

Issue

Vol. 13 (2024): 2024: In Progress

Section

Original Article

License

Copyright (c) 2024 Galen Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

https://creativecommons.org/licenses/by/4.0/